Treatment continuity of amyotrophic lateral sclerosis with available riluzole formulations: state of the art and current challenges in a ‘real-world’ setting-Reference-Cited by-同舟云学术

Treatment continuity of amyotrophic lateral sclerosis with available riluzole formulations: state of the art and current challenges in a ‘real-world’ setting

Published:2024-07-07 Issue: Volume: Page:1-7
ISSN:2167-8421
Container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
language:en
Short-container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Author:

Corcia Philippe¹,Guy Nathalie²,Pradat Pierre-François³,Soriani Marie-Helene⁴,Verschueren Annie⁵^ORCID,Couratier Philippe⁶

Affiliation:

1. CHRU Bretonneau, Centre de Référence SLA et autres maladies du neurone moteur, Tours, France

2. Centre de Référence SLA et autres maladies du neurone moteur, CHU de Clermont-Ferrand; Inserm Neuro-Dol U1107, Université Clermont Auvergne, Clermont-Ferrand, France

3. Centre de Référence SLA et autres maladies du neurone moteur, Hôpital Pitié-Salpêtrière APHP, Sorbonne Université, Paris, France

4. Centre de Référence SLA et autres maladies du neurone moteur, CHU de Nice, Hôpital Pasteur 2, Nice, France

5. Centre de Référence SLA et autres maladies du neurone moteur, Hôpital de la Timone, Marseille, France, and

6. Centre de Référence SLA et autres maladies du neurone moteur, CHU Dupuytren 1, Limoges, France

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678421.2024.2375330

Reference51 articles.

1. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis

2. Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis

3. Amyotrophic lateral sclerosis

4. Amyotrophic lateral sclerosis: a clinical review

5. Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment